AMD3100 (Plerixafor) Given to NHL and MM Patients to Increase the Number of PBSCs When Given a Mobilizing Regimen of G-CSF

Clinical trial NCT00396266 · COMPLETED

Trial details

NCT number: NCT00396266
Sponsor: Genzyme, a Sanofi Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma Lymphoma, Non-Hodgkin

Start date: 2005-01-01
Primary completion: 2007-12-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.